Literature DB >> 18608395

The relationship between upper limb activity and impairment in post-stroke hemiplegia.

Jane H Burridge1, Ruth Turk, Scott V Notley, Ruth M Pickering, David M Simpson.   

Abstract

PURPOSE: To investigate the relationship between upper limb impairments and activity limitation.
METHOD: A cross sectional, single assessment observational study in which people with hemiplegia as a result of a stroke underwent a testing procedure in an instrumented wrist rig in which the following measures of impairment were recorded: Spasticity; motor control (ability to track a moving target); muscle activation patterns during tracking; stiffness; range of active movement and isometric muscle strength. Participants also performed clinical tests of upper limb activity (Action Research Arm Test) and hyper-tonicity (Modified Ashworth Scale).
RESULTS: Seventeen people with hemiplegia whose mean age was 57 (SD 13.4) took part. Their mean upper limb activity, measured by the Action Research Arm Test, was 19.3 (SD 11.2). Statistically significant positive relationships between level of activity and the negative features of the upper motor neuron syndrome such as motor control r = 0.710 (p = 0.003), active range of movement r = 0.540 (p = 0.025) and strength into flexion r = 0.515 (p = 0.034) and extension r = 0.575 (p = 0.016) were identified, but not with the positive features, such as spasticity or the secondary features such as stiffness.
CONCLUSIONS: The negative features of the upper motor neuron syndrome appear more likely to affect upper limb activity than the positive or secondary features, but findings need confirming in different study populations, preferably with larger samples.

Entities:  

Mesh:

Year:  2009        PMID: 18608395     DOI: 10.1080/09638280701824699

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  6 in total

1.  Psychometric properties of measures of upper limb activity performance in adults with and without spasticity undergoing neurorehabilitation-A systematic review.

Authors:  Shannon Pike; Anne Cusick; Kylie Wales; Lisa Cameron; Lynne Turner-Stokes; Stephen Ashford; Natasha A Lannin
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

2.  Gains Across WHO Dimensions of Function After Robot-Based Therapy in Stroke Subjects.

Authors:  Jennifer Wu; Lucy Dodakian; Jill See; Erin Burke Quinlan; Lisa Meng; Jeby Abraham; Ellen C Wong; Vu Le; Alison McKenzie; Steven C Cramer
Journal:  Neurorehabil Neural Repair       Date:  2020-10-21       Impact factor: 3.919

3.  Pediatric Arm Function Test: reliability and validity for assessing more-affected arm motor capacity in children with cerebral palsy.

Authors:  Gitendra Uswatte; Edward Taub; Angi Griffin; Jan Rowe; Laura Vogtle; Joydip Barman
Journal:  Am J Phys Med Rehabil       Date:  2012-12       Impact factor: 2.159

4.  Intense Arm Rehabilitation Therapy Improves the Modified Rankin Scale Score: Association Between Gains in Impairment and Function.

Authors:  Steven C Cramer; Vu Le; Jeffrey L Saver; Lucy Dodakian; Jill See; Renee Augsburger; Alison McKenzie; Robert J Zhou; Nina L Chiu; Jutta Heckhausen; Jessica M Cassidy; Walt Scacchi; Megan Therese Smith; A M Barrett; Jayme Knutson; Dylan Edwards; David Putrino; Kunal Agrawal; Kenneth Ngo; Elliot J Roth; David L Tirschwell; Michelle L Woodbury; Ross Zafonte; Wenle Zhao; Judith Spilker; Steven L Wolf; Joseph P Broderick; Scott Janis
Journal:  Neurology       Date:  2021-02-15       Impact factor: 9.910

Review 5.  Valid and reliable instruments for arm-hand assessment at ICF activity level in persons with hemiplegia: a systematic review.

Authors:  Ryanne J M Lemmens; Annick A A Timmermans; Yvonne J M Janssen-Potten; Rob J E M Smeets; Henk A M Seelen
Journal:  BMC Neurol       Date:  2012-04-12       Impact factor: 2.474

Review 6.  The gap between clinical gaze and systematic assessment of movement disorders after stroke.

Authors:  Hanneke J M van der Krogt; Carel G M Meskers; Jurriaan H de Groot; Asbjørn Klomp; J Hans Arendzen
Journal:  J Neuroeng Rehabil       Date:  2012-08-27       Impact factor: 4.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.